Study S003199

Effect of NNC0487-0111 on Insulin Sensitivity and Pancreatic Endocrine Function in Adults With Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07535307
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: QUADRUPLE
Status: RECRUITING
Enrollment: 80
Start: 2026-04-10
Primary completion: 2027-11-11
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes Mellitus
Interventions: DRUG:NNC0487-0111; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1320-4780; OTHER:2025-521595-55; NIH:2025

Registered primary outcomes

Change in M-value in Hyperinsulinaemic euglycaemic clamp (HEC) [Baseline to week 40]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.